Progress report of a phase II and a phase III trial with etanidazole (SR-2508): a multicentre european study
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 20, 121-127
- https://doi.org/10.1016/0167-8140(91)90199-q
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 studyInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: Influence on repair of potentially lethal damageInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Hypoxia-mediated druGS FOR RADIATION AND CHEMOTHERAPYCancer, 1981
- SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical useInternational Journal of Radiation Oncology*Biology*Physics, 1981